70results about How to "Does not increase the burden on liver and kidney" patented technology

The invention discloses an obliterative cholangitis postoperative navel applying agent and a preparation method thereof, aiming at solving a treatment problem of the obliterative cholangitis. The preparation method is characterized by comprising the following steps of (1), distilling tetrapanax papyriferum, pleurotus and radix sophorae flavescentis with vapor, extracting volatile oil for future use, and reserving dregs; (2), crushing geckos and rice-grain sprouts into fine powder for future use; (3), uniformly mixing prismatomeria tetrandra, gulfweeds, poncirus barks, equisetum hiemale, ternate buttercup roots, wild mints, leaves and twigs of common claoxylon and the dregs obtained in the step (1) for alcohol extraction twice, mixing two-time alcohol extracts, filtering, recycling alcohol and decompressing and concentrating to obtain extract; and (4), adding the fine powder obtained in the step (2) into the extract obtained in the step (3), uniformly mixing, drying at 60 DEG C, crushing into fine powder, adding polysorbate-80 to prepare particles, drying, granulating, spraying the volatile oil obtained in the step (1), uniformly mixing, and sub-packaging to obtain the agent. Clinical experiment proves that the obliterative cholangitis postoperative navel applying agent has characteristics of good curative effect and high safety for bypass postoperative use of the obliterative cholangitis, and is worthy of clinical application and popularization.

The invention discloses a traditional Chinese medicine for treating postoperative pneumonia, and the traditional Chinese medicine is used for solving a treatment problem of the postoperative pneumonia. The traditional Chinese medicine is characterized by being formed by processing various Chinese herbal medicines and being prepared from the following raw materials in parts by weight: 10-20 parts of chuanposhi, 8-15 parts of medicinal cyathula roots, 8-15 parts of herba aistolochiae, 6-10 parts of sunglo, 6-10 parts of fagopyrum dibotrys stems and leaves, 8-15 parts of semen cuscutae, 6-10 parts of Chinese starjasmine stems, 8-15 parts of vandenboschia auriculata and 3-6 parts of alpinia japonica. According to the clinical experiment, the traditional Chinese medicine disclosed by the invention has the characteristics of good curative effect and high safety in treating postoperative pneumonia, and is worthy of being popularized and applied clinically.

The invention discloses a medicament for treating post-traumatic pneumonia, which is used for solving the treatment problem of post-traumatic pneumonia. The medicament is characterized by being processed by various Chinese medicinal herbs, and comprises the following raw materials in parts by weight: 10-20 parts of cudrania roots, 8-15 parts of herbs of dense flower bulbophyllum, 8-15 parts of alyxia sinensis, 6-10 parts of Chinese usnea, 6-10 parts of golden buckwheat rhizomes, 8-15 parts of cuscuta chinensis, 6-10 parts of Chinese starjasmine stems, 8-15 parts of angelica and 3-6 parts of alpinia japonica. Clinical experiments prove that the medicament for treating post-traumatic pneumonia disclosed by the invention has the characteristics of good curative effect and high safety, and is worthy of clinical application and promotion.

The invention discloses a postoperative drug for chronic peptic ulcer and esophagitis syndrome. The drug is applied to the postoperative treatment of chronic peptic ulcer and esophagitis syndrome. The drug is characterized by being prepared from the following raw pharmaceutical materials in proportioning ratio by weight: litchi chinensis Sonn., lindernia ruellioides (Colsm.)Pennell, polygonum orientale L., radix platycodi, aeschynomene indica L., trachelospermum jasminoides (Lindl.) Lem., radix puerariae, paris polyphylla Sm., luffa cylindrica (L.) Roem., manis pentadactyla Linnaeus, hordeum vulgare L. and setaria italica (L.) Beauv.. Proved by clinical trials, the drug has the characteristics of low recurrence rate and high safety in the postoperative treatment of chronic peptic ulcer and esophagitis syndrome, so that the method is worthy of clinical application and popularization.

The invention discloses enema particles for treating diabetic nephropathy and a preparation method for the enema particles. The problem that the diabetic nephropathy is difficult to treat is solved. The preparation method is characterized by comprising the following steps of (1) extracting essential oil from seeds of Chinese dodder, chingma abutilon seeds and angiospermae by steam distillation, and reserving the essential oil and dregs; (2) smashing gecko and coked rice sprout into fine powder, and reserving the fine powder; (3) performing blending and alcohol extraction on fructus cannabis, timonius arboreus, poncirus bark, allium victorialis, stem leaves of wild buckwheat rhizome, Chinese starjasmine stems, vandenboschia and dregs obtained from the step (1) twice, combining alcohol extracts, filtering the alcohol extracts, recycling ethyl alcohol, and performing vacuum concentration on the ethyl alcohol to obtain extractum; and (4) adding the fine powder obtained from the step (2) in the extractum obtained from the step (3), blending the fine powder and the extractum, drying the mixture at the temperature of 60 DEG C, smashing the mixture into fine powder, adding polysorbate-80 in the mixture to obtain particles, drying and granulating the particles, spraying the essential oil obtained from the step (1) in the particles, blending the particles and the essential oil, and separately packaging the particles to obtain the enema particles. A clinical experiment proves that the enema particles for treating the diabetic nephropathy have high curative effect and high safety, and are worthy of being clinically applied and popularized.

The invention discloses a pharmaceutical composition for treating postpartum neurosis intestinal obstruction in order to solve the treatment problem of the postpartum neurosis intestinal obstruction. The pharmaceutical composition is characterized by comprising raw materials including, by weight, aspongopus chinensis dallas, alyxia, timonius arboreus, scandent schefflera root, wikstroemia micrantha hemsl, allium victorialis L, mulberries, ranunculus ternatus thumb, Chinese starjasmine stem, amblystegium serpens, cinnamomum cassia presl and setaria italica beauv. Clinical trials prove that the pharmaceutical composition has the advantages of good curative effect on postpartum neurosis intestinal obstruction, high security, and being worthy of clinical application and promotion.

The invention discloses a belly patch for treating intestinal dysfunction after abdominal cavity surgery and a preparation method of the belly patch, and solves the problem of the intestinal dysfunction after the abdominal cavity surgery. The invention is characterized in that the preparation method comprises the following steps: (1) distilling tall gastrodia fruit, alyxia sinensis and pimpinella diversifolia with steam, and collecting volatile oil and residues for standby use; (2) grinding azurite and charred rice sprouts into fine powders for standby use; (3) thoroughly mixing aspongopus, timonius arboreus, jasminum grandiflorum flower, allium victorialis, spatholobus stem, flueggea suffruticosa, ramulus cinnamomi and residues obtained from the step (1), extracting with ethanol twice, mixing the extraction liquids, filtering, recovering ethanol and concentrating under reduced pressure to obtain a soft extract; (4) adding the fine powders from the step (2) into the soft extract from the step (3), oven-drying at 60 DEG C, grinding into fine powder, adding polysorbate-80, making granules, oven-drying, grading, spraying with the volatile oil obtained from the step (1), thoroughly mixing, packaging and applying to the bellybutton. Clinical trials show that the belly patch has the characteristics of good curative effect and relatively high safety, and is worthy of clinical application and promotion.

The invention discloses a drug composition used after mitral valve calcification valvuloplasty, which is used for solving the problem of treatment of mitral valve calcification. The drug composition is characterized by being prepared from the following active pharmaceutical ingredients by weight: persimmon barks, dahurian rose fruit, Sargassumthunbergii(Mert.)O.Kuntze, Poncirus trifollata(L.)Raf., bark or root of littleflower stringbush, common scouring rush herb, rice-paper plant, root of catclaw buttercup, Chinese starjasmine stem, geckos, nakedflower beautyberry branchlet and leaf and fried rice grain sprouts. Clinical experiments prove that used after mitral valve calcification valvuloplasty, the drug composition has the characteristics of good curative effects and relatively high safety and is worthy of clinical application and popularization.

The invention discloses a capsule for treating alcoholic cardiomyopathy and a preparation method thereof. The capsule is applied to the therapy of alcoholic cardiomyopathy. The preparation method is characterized by comprising the steps of (1) distilling Gastrodia elata Bl., Stachys kouyangensis (Van.) Dunn and Sophora flavescens Ait. by water vapor, so as to extract volatile oil for later use, and enabling dregs to be standby; (2) crushing Gekko gecko Linnaeus and Setaria italica (L.) Beauv. into fine powder for later use; (3) uniformly mixing Selaginella tamariscina (Beauv.) Spring, Begonia handelii Irmsch., Poncirus tuifoliata (L.) Raf., Polygonum aviculare L., Ranunculus ternatus Thunb., Dracocephalum moldavica L., Callicarpa nudiflora Hook. Et Arn. and the dregs obtained in the step (1), carrying out ethanol extraction twice, merging two alcohol extracts, filtrating, recovering ethanol, and carrying out depressurized concentration, so as to form an extract; (4) adding the fine powder obtained in the step (2) into the extract obtained in the step (3), uniformly mixing, drying at the temperature of 60 DEG C, crushing into fine powder, adding polysorbate-80, granulating, drying, finishing, spraying the volatile oil obtained in the step (1), uniformly mixing, and encapsulating, thereby obtaining the capsule. Proved by clinical trials, the capsule has the characteristics of good treatment effect and relatively high safety in the therapy of alcoholic cardiomyopathy, so that the capsule is worthy of clinical application and popularization.

The invention discloses a pharmaceutical composition used after obliterative cholangitis surgical shunt. The pharmaceutical composition is used for solving obliterative cholangitis treatment problems, and is characterized by comprising, by weight, radix prismatomeris connatae, pleurotus, sargassum, poncirus barks, sophora flavescens, equisetum hyemale, gastrodia elata fruits, radix ranunculi ternati, moldavian dragon's-head, gecko, nakedflower beautyberry branchlet and leaves and scorched rice sprouts. As proved by clinical trial, the pharmaceutical composition used after the obliterative cholangitis surgical shunt has the advantages of good curative effect and high safety, and is worthy of clinical application and popularization.

The invention discloses a pharmaceutical composition for treating senile calcific valve disease. The pharmaceutical composition is applied to the therapy of cardiac valve calcification. The pharmaceutical composition is characterized by being prepared from the following raw pharmaceutical materials in proportion by weight: Diospyros kaki Thunb., Rosa davurica Pall., Usnea diffracta Vain., Poncirus tuifoliata (L.) Raf., Wikstroemia micrantha Hemsl., Equisetum hiemale L., Gastrodia elata Bl., Bulbophyllum reptans Lindl., Akebia trifoliata Koidz., Gekko gecko Linnaeus, Callicarpa nudiflora Hook. Et Arn. and Setaria italica (L.) Beauv.. Proved by clinical trials, the pharmaceutical composition has the characteristics of good treatment effect and relatively high safety in the therapy of senile calcific valve disease, so that the pharmaceutical composition is worthy of clinical application and popularization.